Farzan Siddiqui, MD, PhD, CPE

Chair, Henry Ford Medical Group Board of Governors
Vice-Chair, Department Operations
Director, Head and Neck Radiation Program
Department of Radiation Oncology
Clinical Professor, Michigan State University College of Human Medicine
Clinical Associate Professor, Wayne State University School of Medicine
Adjunct Professor, University of Detroit Mercy School of Dentistry

Dr. Siddiqui is a Radiation Oncologist at Henry Ford Health-Cancer. He is board certified in Radiation Oncology and Hospice & Palliative Medicine. He serves as the Vice-Chair of Radiation Oncology and is the Co-Director of the Head and Neck Oncology program at Henry Ford Health. He has academic appointments as a Professor, College of Human Medicine, Michigan State University and Adjunct Professor at the University of Detroit Mercy School of Dentistry.

He did his medical schooling at Grant Medical College, Mumbai, India followed by a residency at Tata Memorial Hospital, Mumbai, India. Following completion of his residency training in India, he moved to the United States to pursue a Ph.D. in Radiation Biology and Cancer Gene therapy at Colorado State University, Fort Collins, CO. He then did a second radiation oncology residency at Henry Ford Hospital.

Dr. Siddiqui is a recognized expert in the treatment of head and neck and skin cancers and has led various expert panels in publishing treatment guidelines for these cancers. He served as the Chair of the American Radium Society Appropriate Use Criteria committee for head and neck cancers. Recently has been selected as the vice-chair of the American Society for Radiation Oncology (ASTRO) Scientific committee. This is a three-year term, following which he will be taking over as chair for the next three years. ASTRO is the largest radiation oncology society in the world with over 10,000 members including radiation oncologists, medical physicists, radiation biologists and other allied health professionals. It has a profound impact on cancer care across the globe setting the standards for radiation oncology practice.

He is also a co-principal investigator on many national and international cooperative group clinical trials. He has also successfully led and conducted investigator initiated clinical trials at Henry Ford Health while serving as the clinical lead for the cancer gene therapy trials being conducted in the Department of Radiation Oncology. He has over 125 peer-reviewed publications in prestigious scientific journals and over 10 book chapters.